Search Results - "Veys, P"

Refine Results
  1. 1
  2. 2

    T cell depletion in paediatric stem cell transplantation by Booth, C., Veys, P.

    Published in Clinical and experimental immunology (01-05-2013)
    “…Summary Haematopoietic stem cell transplantation (HSCT) can be a curative procedure for a growing number of paediatric diseases, but as the indications for…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients by Hiwarkar, P, Gaspar, H B, Gilmour, K, Jagani, M, Chiesa, R, Bennett-Rees, N, Breuer, J, Rao, K, Cale, C, Goulden, N, Davies, G, Amrolia, P, Veys, P, Qasim, W

    Published in Bone marrow transplantation (Basingstoke) (01-06-2013)
    “…While pre-emptive rituximab therapy for EBV has substantially reduced the incidence of post-transplant lymphoproliferative disorder, following allogeneic…”
    Get full text
    Journal Article
  5. 5

    Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases by Slatter, M A, Boztug, H, Pötschger, U, Sykora, K-W, Lankester, A, Yaniv, I, Sedlacek, P, Glogova, E, Veys, P, Gennery, A R, Peters, C

    Published in Bone marrow transplantation (Basingstoke) (01-12-2015)
    “…An increasing number of children with non-malignant diseases can be cured by allogeneic haematopoietic stem cell transplantation (HSCT). Treosulfan ( L…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience by O'Hare, P, Lucchini, G, Cummins, M, Veys, P, Potter, M, Lawson, S, Vora, A, Wynn, R, Peniket, A, Kirkland, K, Pearce, R, Perry, J, Amrolia, P J

    Published in Bone marrow transplantation (Basingstoke) (01-06-2017)
    “…We report outcomes for 44 children who underwent stem cell transplantation (SCT) for refractory AML in the UK between 2000 and 2012. Median age at SCT was 11.5…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    A mass spectrometry method for sensitive, specific and simultaneous detection of bovine blood meal, blood products and milk products in compound feed by Lecrenier, M.C., Planque, M., Dieu, M., Veys, P., Saegerman, C., Gillard, N., Baeten, V.

    Published in Food chemistry (15-04-2018)
    “…•A multi-target LC-MS/MS method to detect bovine by-products in feed was developed.•The method reaches the LOD required by the legislation into force…”
    Get full text
    Journal Article Web Resource
  11. 11

    The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis by Cooper, N, Rao, K, Goulden, N, Webb, D, Amrolia, P, Veys, P

    Published in Bone marrow transplantation (Basingstoke) (01-10-2008)
    “…Allogeneic stem cell transplant is curative for haemophagocytic lymphohistiocytosis (HLH) and refractory Langerhans cell histiocytosis (LCH). However, patients…”
    Get full text
    Journal Article
  12. 12

    Predicting CD4 T‐Cell Reconstitution Following Pediatric Hematopoietic Stem Cell Transplantation by Hoare, RL, Veys, P, Klein, N, Callard, R, Standing, JF

    Published in Clinical pharmacology and therapeutics (01-08-2017)
    “…Hematopoietic stem cell transplantation (HSCT) is an increasingly common treatment for children with a range of hematological disorders. Conditioning with…”
    Get full text
    Journal Article
  13. 13

    Identification of specific bovine blood biomarkers with a non-targeted approach using HPLC ESI tandem mass spectrometry by Lecrenier, M.C., Marbaix, H., Dieu, M., Veys, P., Saegerman, C., Raes, M., Baeten, V.

    Published in Food chemistry (15-12-2016)
    “…•Selection of the proteins of interest using an analytical approach.•Identification of specific bovine and porcine biomarkers to detect processed blood.•Two…”
    Get full text
    Journal Article Web Resource
  14. 14

    Nephropathic Cystinosis: Pathogenic Roles of Inflammation and Potential for New Therapies by Elmonem, Mohamed A, Veys, Koenraad R P, Prencipe, Giusi

    Published in Cells (Basel, Switzerland) (06-01-2022)
    “…The activation of several inflammatory pathways has recently been documented in patients and different cellular and animal models of nephropathic cystinosis…”
    Get full text
    Journal Article
  15. 15

    Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure by BOELENS, J. J, WYNN, R. F, SEDLACEK, P, ROVELLI, A, UITERWAAL, C. S. P. M, WULFFRAAT, N, O'MEARA, A, VEYS, P, BERTRAND, Y, SOUILLET, G, WRAITH, J. E, FISCHER, A, CAVAZZANA-CALVO, M, SYKORA, K. W

    Published in Bone marrow transplantation (Basingstoke) (01-08-2007)
    “…Hurler's syndrome (HS), the most severe form of mucopolysaccharidosis type-I, causes progressive deterioration of the central nervous system and death in…”
    Get full text
    Journal Article
  16. 16

    Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases by Satwani, P, Cooper, N, Rao, K, Veys, P, Amrolia, P

    Published in Bone marrow transplantation (Basingstoke) (01-01-2008)
    “…Allogeneic hematopoietic SCT is well established as a potentially curative therapy for children and adults with both malignant and nonmalignant diseases…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20